Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy

Kidney International

Volumn 85, Issue 6, 2014, Pages 1318-1329

  Song, Kai ^a,b   Wang, Fen ^a   Li, Qian ^a   Shi, Yong Bing ^b   Zheng, Hui Fen ^a   Peng, Hanjing ^c   Shen, Hua Ying ^b   Liu, Chun Feng ^a,b   Hu, Li Fang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

cell signaling; chronic inflammation; chronic renal disease

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL NUCLEUS ANTIGEN; COLLAGEN; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; ENALAPRIL; HYDROGEN SULFIDE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYC PROTEIN; PROPARGYLGLYCINE; SMAD PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ACTIN; AUTACOID; CYTOKINE; SMOOTH MUSCLE ACTIN, RAT; SODIUM BISULFIDE; SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; EXTRACELLULAR MATRIX; FIBROBLAST; KIDNEY FIBROSIS; LOW DRUG DOSE; MACROPHAGE; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; URETER OBSTRUCTION; ANIMAL; CELL LINE; CELL PROTECTION; COMPLICATION; DISEASE MODEL; DNA REPLICATION; DOSE RESPONSE; DRUG EFFECTS; FIBROSIS; KIDNEY; KIDNEY DISEASES; METABOLISM; NEPHRITIS, INTERSTITIAL; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TIME; URETERAL OBSTRUCTION;

ACTINS; ANIMALS; CELL LINE; CELL PROLIFERATION; COLLAGEN; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FIBROSIS; HYDROGEN SULFIDE; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEPHRITIS, INTERSTITIAL; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SULFIDES; TIME FACTORS; URETERAL OBSTRUCTION;

EID: 84901852765     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.449     Document Type: Article

References (46)

1. Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med 2006; 57: 365-380.
2. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
3. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656.
4. Boor P, Sebeková K, Ostendorf T et al. Treatment targets in renal fibrosis. Nephrol Dial Transplant 2007; 22: 3391-3407.
5. Wang R. Shared signaling pathways among gasotransmitters. Proc Natl Acad Sci USA 2012; 109: 8801-8802.
6. Xia M, Chen L, Muh RW et al. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 2009; 329: 1056-1062.
7. Be"towski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther 2010; 334: 358-363.
8. Aminzadeh M, Vaziri N. Down-regulation of the renal and hepatic hydrogen sulfide (H2S) producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant 2012; 27: 498-504.
9. Perna AF, Luciano MG, Ingrosso D et al. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 2009; 24: 3756-3763.
10. Sen U, Basu P, Abe OA et al. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol 2009; 297: F410-F419.
11. Fang L, Li H, Tang C et al. Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats. Can J Physiol Pharmacol 2009; 87: 531-538.
12. El-Seweidy MM, Sadik NA, Shaker OG. Role of sulfurous mineral water and sodium hydrosulfide as potent inhibitors of fibrosis in the heart of diabetic rats. Arch Biochem Biophys 2011; 506: 48-57.
13. Tan G, Pan S, Li J et al. Hydrogen sulfide attenuates carbon tetrachlorideinduced hepatotoxicity, liver cirrhosis and portal hypertension in rats. PLoS One 2011; 6: e25943.
14. Morrissey JJ, Ishidoya S, Mc Cracken R et al. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1996; 7: 2202-2212.
15. Wang L, Lee JY, Kwak JH et al. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction. Am J Physiol Renal Physiol 2008; 294: F508-F517.
16. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
17. Bos EM, Wang R, Snijder PM et al. Cystathionine g-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol 2013; 24: 759-770.
18. Wu N, Siow YL, Karmin O. Ischemia/reperfusion reduces transcription factor SP1 mediated cystathionine b-synthase expression in the kidney. J Biol Chem 2010; 285: 18225-18233.
19. Tripatara P, Patel NSA, Collino M et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048.
20. Lee HJ, Mariappan MM, Feliers D et al. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. J Biol Chem 2012; 287: 4451-4461.
21. Pan TT, Chen YQ, Bian JS. All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment. Eur J Pharmacol 2009; 616: 160-165.
22. Whitfield NL, Kreimier EL, Verdial FC et al. Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr CompPhysiol 2008; 294: R1930-R1937.
23. Zhong G, Chen F, Cheng Y et al. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003; 21: 1879-1885.
24. Peng H, Cheng Y, Dai C et al. A fluorescent probe for fast and quantitative detection of hydrogen sulfide in blood. Angew Chem Int Ed Engl 2011; 50: 9672-9675.
25. Wintner EA, Deckwerth TL, Langston W et al. A monobromobimanebased assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 2010; 160: 941-957.
26. Zhang BH, Wu FY, Wu YM et al. Fluorescent method for the determination of sulfide anion with ZnS:Mn quantum dots. J Fluoresc 2010; 20: 243-250.
27. Della Coletta Francescato H, Cunha FQ, Costa RS et al. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage. Nephrol Dial Transplant 2011; 26: 479-488.
28. Francescato HD, Marin EC, Cunha Fde Q et al. Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection. Arch Toxicol 2011; 85: 1597-1606.
29. Burnett G, Marcotte P, Walsh C. Mechanism-based inactivation of pig heart L-alanine transaminase by L-propargylglycine. Half-site reactivity. J Biol Chem 1980; 255: 3487-3491.
30. Marcotte P, Walsh C. Active site-directed inactivation of cystathionine g-synthetase and glutamic pyruvic transaminase by propargylglycine. Biochem Biophys Res Commun 1975; 62: 677-682.
31. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
32. Fang LP, Lin Q, Tang CS et al. Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts. Pulm Pharmacol Ther 2009; 22: 554-561.
33. Schwer CI, Stoll P, Goebel U et al. Effects of hydrogen sulfide on rat pancreatic stellate cells. Pancreas 2012; 41: 74-83.
34. Baskar R, Bian J. Hydrogen sulfide gas has cell growth regulatory role. Eur J Pharmacol 2011; 656: 5-9.
35. Baskar R, Li L, Moore PK. Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J 2007; 21: 247-255.
36. Yang G, Wu L, Bryan S et al. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res 2010; 86: 487-495.
37. Bö ttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610.
38. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23.
39. Hao S, Shen H, Hou Y et al. tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling. Am J Pathol 2010; 177: 1164-1175.
40. Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006; 17: 2999-3012.
41. Deplancke B, Gaskins HR. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003; 17: 1310-1312.
42. Ma FY, Sachchithananthan M, Flanc RS et al. Mitogen activated protein kinases in renal fibrosis. Front Biosci (Schol Ed) 2009; 1: 171-187.
43. Lee SB, Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int SUPPL. 2010; 78: S22-S26.
44. Wallace JL, Ferraz JG, Muscara MN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signal 2012; 17: 58-67.
45. Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012; 92: 689-737.
46. Hu LF, Lu M, Tiong CX. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 2010; 9: 135-146.